Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle

P R Strege1, S Evangelista, G L Lyford

  • 1Enteric NeuroScience Program, Mayo Clinic, Rochester, MN 55905, USA.

Insights

Otilonium bromide (OB) effectively inhibits L-type calcium channels in human intestinal smooth muscle cells. This action, observed at clinical concentrations, likely explains OB's antispasmodic effects by blocking calcium entry.

Area of Science:

  • Pharmacology
  • Cell Physiology
  • Gastroenterology

Background:

  • Otilonium bromide (OB) is a clinically used intestinal antispasmodic.
  • Its precise mechanism of action remains incompletely understood.
  • Calcium ion (Ca2+) influx is critical for intestinal smooth muscle contraction.

Purpose of the Study:

  • To investigate the effects of OB on Ca2+, sodium (Na+), and potassium (K+) ion channels.
  • To determine if OB specifically targets L-type Ca2+ channels in human jejunal smooth muscle.
  • To validate findings using heterologously expressed L-type Ca2+ channels.

Main Methods:

  • Patch clamp electrophysiology was employed to record whole-cell currents.
  • Experiments were conducted on human jejunal circular smooth muscle cells.
  • L-type Ca2+ channels expressed in HEK293 cells were also studied.

Main Results:

  • Otilonium bromide significantly inhibited L-type Ca2+ currents in human smooth muscle cells in a dose-dependent manner (25% at 0.9 µmol/L, 90% at 9 µmol/L).
  • OB demonstrated no significant effect on Na+ or K+ currents in these cells.
  • In HEK293 cells, 1 µmol/L OB markedly inhibited expressed L-type Ca2+ channels, independent of specific subunit termini.

Conclusions:

  • Otilonium bromide inhibits Ca2+ influx through L-type Ca2+ channels at concentrations relevant to clinical intestinal tissue levels.
  • This inhibition of Ca2+ channels is a likely mechanism underlying the muscle relaxant and antispasmodic properties of otilonium bromide.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...